ClinTec International will formally open an office in Istanbul, Turkey. The office will provide ClinTec’s global team with access to a new patient population, and further consolidate the British CRO’s presence in the Middle East and North Africa (MENA) region.
Dr Rabinder Buttar, Founder and Chief Executive Officer, ClinTec International said, “The launch of this new office in Turkey reflects the growing significance of Turkey- and the wider MENA region- to the global clinical research market. We are delighted to be at the forefront of developing expertise in Turkey and the MENA region as a whole.”
The company is also sponsoring partnerships in Clinical Trials at Russia-CIS and MENA-Turkey conference to be held in Istanbul on May 22 – 23, 2013. The conference aims to explore the challenges and opportunities facing companies when conducting clinical trials in the MENA region. Bindhya Cariappa, Executive Vice-President- Global Clinical Development ClinTec’s will be delivering a speech on Rare Disease Trials in the MENA region.
EP News Bureau – Mumbai